Healthcare Realty Trust Inc (HR) Q1 2026 Earnings Call Transcript

Why It Matters

The results demonstrate that HR’s strategic overhaul is delivering earnings upside and balance‑sheet flexibility, positioning the REIT for sustainable dividend support and growth in a tight outpatient medical real‑estate market.

Key Takeaways

• Normalized FFO $1.61 per share, beating guidance.
• Same‑store NOI grew 4.8%, surpassing target.
• $1.2 B asset sales reduced net debt to 5.4x EBITDA.
• New $600 M commercial paper program boosts liquidity.
• Tenant retention hit 82% with health‑system lease renewals.

Pulse Analysis

Healthcare Realty Trust (HR) has emerged as a bellwether for outpatient medical real‑estate investors, delivering normalized FFO of $1.61 per share and a 4.8% same‑store NOI increase—both comfortably ahead of its own forecasts. These metrics underscore the effectiveness of the three‑year strategic plan launched in mid‑2025, which emphasized tighter asset management, cost discipline, and targeted disposals. By shedding $1.2 billion of non‑core assets at a 6.7% cap rate, the REIT trimmed net debt to a 5.4x EBITDA ratio, restoring balance‑sheet resilience and unlocking capital for shareholder returns.

Leasing momentum has been a cornerstone of HR’s performance. The company recorded 5.8 million square feet of lease activity, including 1.6 million square feet of new leases, while tenant retention climbed to 82%—the highest in its recent history. Strong partnerships with leading health systems such as Tufts Medicine, Advocate Health, and Hartford HealthCare have driven both renewals and expansions, delivering a 1,000‑basis‑point surge in redevelopment lease uptake. Occupancy gains of over 100 basis points and cash leasing spreads above 5% reflect a market where outpatient demand outpaces supply, reinforcing HR’s premium positioning in high‑growth MSAs.

Capital allocation remains disciplined yet opportunistic. A $600 million commercial paper program adds funding flexibility, complementing a $50 million share repurchase and a dividend yielding nearly 6%. With redevelopment yields targeting roughly 10% on cost and a pipeline of joint‑venture opportunities, HR aims to generate incremental NOI without diluting earnings. The 2026 guidance, while flat on a headline basis, embeds about 5% core earnings growth and anticipates free cash flow of roughly $100 million, signaling a compelling value proposition for investors seeking stable income and upside in the healthcare REIT sector.